DSAM Partners’s Kyntra Bio KYNB Stock Holding History

DSAM Partners’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,125	Closed	-$3.5K	–	47
2014 Q4	$3.5K	Buy	+5,125	New	+$3.3M	0.92%	25

Other funds holding KYNB

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

DSAM Partners's KYNB Position: Q1 2015 in Review

DSAM Partners sold out of Kyntra Bio (KYNB) in Q1 2015, closing a stake of 5,125 shares — an estimated $3.5K sold.

DSAM Partners first reported a position in KYNB in Q4 2014 and held it in 1 quarter. The position peaked at $3.5K in Q4 2014. 76 funds tracked by Wall St. Rank hold KYNB as of Q1 2015.

DSAM Partners reported no remaining Kyntra Bio position as of Q1 2015 after selling out during the quarter.
DSAM Partners sold 5,125 Kyntra Bio shares in Q1 2015, an estimated $3.5K.
DSAM Partners first reported a position in Kyntra Bio in Q4 2014 and held it in 1 quarter.
DSAM Partners's Kyntra Bio position peaked at $3.5K in Q4 2014.
76 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2015.

Based on DSAM Partners's 13F filing for Q1 2015, filed 15 May 2015.